Tech Company Financing Transactions
Enifer Funding Round
Enifer secured a $39 million Series B funding round on 5/23/2024. Investors included Taaleri Bioindustry, Business Finland and Finnish Climate Fund.
Transaction Overview
Company Name
Announced On
5/23/2024
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$39,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to start constructing a food-grade mycoprotein factory in Kirkkonummi, Finland.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Peuraniitty 5 B 25
Espoo, 02750
Finland
Espoo, 02750
Finland
Phone
Website
Email Address
Overview
Enifer is a biotech start-up based in Espoo, Finland, founded in 2020. We harness the power of fungal fermentation to upcycle agrifood industry byproducts into nutritious mycoprotein ingredients. We're building on a proud history of Finnish innovation -- our PEKILO® process was originally developed and commercialized already in 1975!
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Simo Ellilä
Chief Operating Officer
Joosu Kuivanen
Chief Scientific Officer
Anssi Rantasalo
Chief Technical Officer
Ville Pihlajaniemi
Browse more venture capital transactions:
Prev: 5/23/2024: Cowboy Clean Fuels venture capital transaction
Next: 5/23/2024: Dora Factory venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs